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and in schoolchildren it was atropine (8%). The “probable” and 
“possible” class of causality in babies were 57.2% and 17.1% while 
“certain” class was defined just in 24% of reports. In other groups. 
doctors were more sure in ADRs cause: “certain” class was reported 
in 50%.
Conclusion: This analysis confirms results of previous studies which 
suggest ADRs as significant issues in pediatrics, which gender speci-
fity, clinical presentations, ADR causing agent and seriousness differ 
from the same in adults.
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Introduction: Elderly people of Bangladesh have a strong belief 
that Oxalis perdicaria (Molina) Bertero as pulp or extract can con-
trol loose motion. The mechanism of action on Oxalis perdicaria 
(Molina) Bertero extract is not known but the elderly, especially 
grandmothers, use Oxalis perdicaria (Molina) Bertero extracts for 
their grandchildren who suffer from the loose motion.
Patients (or Materials) and Methods: Evaluate control of motion 
and fluid loss as affected by intake of Oxalis perdicaria (Molina) 
Bertero extract. In the observations, 29 children aged 1 to 2 years, 
having > 5 loose motions/d were randomly advised to take 60 mL 
of Oxalis perdicaria (Molina) Bertero extract (extracted from 50 
leafs with stem). The children were suffering from the persistent 
malnutrition diarrhea. They were also feed Khichdi made with 300 
g of rice, 200 g of vegetables, 2 eggs, 150 g of fish, 150 g of len-
tils, and 30 mL of soybean oil. The total amount of Khichdi was 
divided into 3 meals, and after each meal, 60 mL of Oxalis perdi-
caria (Molina) Bertero extract was given to ingest. They were also 
advised to drink oral saline in between the meals, and if capable, 
to eat fruits, such as Aegle marmelos (L.) Corrêa, Citrus maxima 
(Burm.) Osbeck, Mangifera indica L., Musa acuminata Colla, and 
Psidium guajava L. The observations were conducted at the multi-
center during October 2011 to March 2012. None was admitted to 
hospital. Urinary excretion and stool of each patient were examined 
routinely on the first day and fifth day. After 5 days, they were 
advised to eat normal diets.
Results: On the second day, 6 patients showed controlled motion 
(2–3 motions a day). Eleven cases showed controlled motion on the 
third day, 9 cases on the fourth day, and 3 cases on the fifth day. Signs 
of dehydration were absent in 18 cases on the third day, 9 cases on 
the fourth day, and 2 cases on the fifth day. Motion and dehydration 
both were controlled within the 5 days of Oxalis perdicaria (Molina) 
Bertero therapy.
Conclusion: Treatment of diarrhea with the Oxalis perdicaria 
(Molina) Bertero, a common herb in Bangladesh, is not yet estab-
lished, but the observations on 29 cases in the lessons showed 100% 
cure within 5 days. The indigenously available medicines and tech-
nologies can prove an asset in the tropical and developing countries 
of the world. At the same time, developed countries also can be 
benefited because of safety profile of the plant extracts.
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Introduction: We aimed to assess parenteral drug (PD) prescription 
patterns for children under the age of 6 at primary health care centers 
(PHCC) in Turkey, using some drug use indicators.
Patients (or Materials) and Methods: PD prescriptions were recruited 
using the databases of the year 2010 recorded in the PHCC of 32 
provinces in Turkey. One hundred PD prescriptions per month from 
each of the 32 provinces were analyzed retrospectively. Of the total 
38,400 PD prescriptions, 2369 (6.2%) were written out for children 
aged 0 to 5.
Results: PD prescriptions were more often written out for boys 
(56.8%). When age distribution was analyzed, it was found that 
PD prescriptions were most often written out for children at age 2 
(24.1%), followed by age 1 (23.3%), age 3 (17.9%), age 5 (14.5%), 
age 4 (13.6%), and age < 1 children (6.6%). Number of drugs per pre-
scription was 2.8 (1.2), number of PD per prescription was 1.1 (0.3). 
PDs constituted 57.8% of the total costs of these prescriptions. PDs 
were more often written out in winter (29.8%), followed by spring 
(27.0%), summer (24.5%), and autumn (18.7%). Most frequently 
prescribed PDs were ceftriaxone (31.6%), followed by benzathine 
benzylpenicillin (14.3%), cefazoline (8.0%) and ampicillin + sulbac-
tam (7.8%). Most frequent diagnoses on the prescriptions were acute 
tonsillitis (24.5%), followed by acute bronchitis (20.3%), acute phar-
yngitis (6.1%), and acute upper respiratory tract infection (3.8%).
Conclusion: In small children, PDs were more frequently prescribed 
for respiratory tract infection, in winter and third-generation cepha-
losporins were the most frequently prescribed PDs. The overuse of 
third-generation cephalosporins as revealed in our study represent 
a major concern for the public health because it could be associated 
with increased antibiotic resistance.
Disclosure of Interest: None declared.
PP231—acute human tOxicity Of 
thiOPurines, mycOPhenOlate and 
sirOlimus
C. Gregoriano1; A. Ceschi2,3; C. Rauber-Lüthy3;  
H. Kupferschmidt3; S. Krähenbühl1; and A. Taegtmeyer1*
1Clinical pharmacology and toxicology, University Hospital 
Basel; 2Department of Clinical Pharmacology and Toxicology, 
University Hospital Zurich; and 3Swiss Toxicological Information 
Centre, Associated Institute of the University of Zurich, Zurich, 
Switzerland
Introduction: Literature regarding acute human toxicity of thio-
purines and mycophenolate (MMF) is limited to a handful of case 
reports. There are no published reports of sirolimus (SIR) overdose. 
The aim of this study was to investigate the circumstances and out-
comes of overdoses (ODs) with thiopurines, MMF, and SIR using 
data reported to a single national poison center.
Patients (or Materials) and Methods: A retrospective review was 
performed of all acute ODs involving thiopurines (azathioprine 
and 6-mercaptopurine), MMF, and SIR in adults and children (< 16 
years) reported to the Swiss Toxicological Information Centre (STIC) 
between 1995 and 2012.
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Results: Of 152,762 reports to STIC, 55 involved OD with thiopu-
rines (n = 39), MMF (n = 14), or SIR (n = 2). Of these, 32 were with 
suicidal intent, 19 accidental, and 4 iatrogenic errors. Eleven (31%) 
thiopurine, 4 (31%) MMF, and 1 (50%) SIR ODs had attributable 
symptoms. The majority of symptoms were minor, although 1 case 
of sustained thiopurine OD caused agranulocytosis, 1 case of a 9-fold 
MMF OD caused biphasic hypotension (possibly reflecting entero-
hepatic circulation), and 1 case of SIR OD in a child caused tremor, 
raised liver enzymes, and gastroenteritis. Symptoms were observed 
in patients taking 1.5 and 2.4 times or greater than their usual dose 
(or the maximum licensed dose in patients not usually taking medica-
tion) for thiopurines and MMF, respectively. Decontamination meas-
ures were undertaken in 10 thiopurine ODs (9 activated charcoal, 
1 gastric lavage). The OR for the development of symptoms after 
gastrointestinal decontamination in these ODs was 0.14 (95% CI, 
0.01–1.5) compared with cases without decontamination. Charcoal 
was given primarily to children. The mean age of cases managed 
with charcoal was 8 (10) versus 30 (15) years for cases managed 
without (P < 0.0001).
Conclusion: Acute toxicity with thiopurines appears to only be 
significant with a prolonged exposure to high drug concentrations. 
MMF ODs seem to be well tolerated. Physicians should be aware, 
however, that patients who develop hypotension shortly after oral 
OD may relapse some hours later. It seems that SIR is highly toxic in 
young children even at modest degrees of overdose. Gastrointestinal 
decontamination with activated charcoal appeared to reduce symp-
tom development after overdose of thiopurines. Thiopurine, MMF, 
and SIR OD patterns, outcomes, and management require contin-
ued study and transplant and poisons centers should be encouraged 
to actively seek follow-up data on the cases with which they are 
involved.
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Introduction: Pipamperone (PIP) is a mild to moderately potent buty-
rophenone neuroleptic. Its mechanism of action is thought to be the 
antagonism of serotonin 5-HT2A and dopamine D4 receptors. The 
aim of the study was to analyze the clinical features of PIP poison-
ing because information on patterns of toxicity of this substance in 
overdose is scarce and limited to case reports.
Patients (or Materials) and Methods: Retrospective consecutive 
review of acute PIP monointoxications reported by physicians to the 
STIC between August 1974 and November 2012.
Results: Thirty-two adults, 3 teenagers, and 3 children could be 
included. Mean age of the group with adults and teenagers was 41 
years (range, 14–90), and the ingested dose in this group ranged 
between 60 and 2400 mg (mean, 638). Five (14%) patients remained 
asymptomatic, 21 (60%) showed minor, 8 (22%) moderate, and 1 
severe symptoms according to Poisoning Severity Score. There was 
no fatality. Minor symptoms occurred after ingestion of 60 to 1200 
mg PIP (mean, 578), moderate symptoms after 160 to 2400 mg 
(mean, 950), and severe symptoms after 1200 mg. Signs and symp-
toms predominantly involved the central nervous and the cardiovas-
cular systems (Table). An ECG was available in 20 patients, and 
8 showed a prolonged QTc interval (455–505 ms) after ingestion of 
400 to 1600 mg. A previously healthy woman developed a general-
ized seizure after ingestion of 1600 mg. Coma occurred after intake 
of 1200 mg in an adult, and 360 mg in a 4.5-year-old child. Two 
children (2- and 4-year-old) remained asymptomatic after ingestion 
of 10 and 80 mg, respectively.
Conclusion: The severity of poisoning was related to the ingested 
PIP dose. Overdose was associated mostly with mild to moderate, 
neurologic and cardiovascular signs/symptoms. There was 1 acute 
single convulsive episode, which has not been previously described in 
literature. The remarkable frequency of QTc prolongation deserves 
particular attention, since a case of torsades de pointes has been pre-
viously described.1 The relevance of this phenomenon could increase 
in the near future because a fixed combination of low-dose PIP and 
citalopram, which has also QT prolonging potential, is investigated 
in a Phase III study. Poisoned patients should be monitored for central 
nervous system depression, dysrhythmias and QTc prolongation.
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Introduction: Inhabitants of Melun and vicinities have been exposed 
to a waste incinerator (1974–2002) emitting high concentrations of 
dioxins (226 ng I-TEQ/Nm3) up to 2000-times the maximal recom-
mended values. This constitutes a case of unique and well-identified 
source of pollution. Dioxin (TCDD) is a well-described CYP1A 
inducer in vitro but in vivo studies are, however, rare. CYP1A has 
a role in the activation of some environmental and food-borne car-
cinogens and metabolic ratio of paraxanthine (17X) and caffeine 
(1,3,7-trimethylxanthine, 137X) is used as a measure of its activity. 
The aim of the study was to assess the exposed population through 
Table.  Symptoms/signs with classification according to severity 
(Poisoning Severity Score).
Severity
Symptom/Sign Minor n (%) Moderate n (%) Severe n (%)
Somnolence 15 (39)
Coma 2 (5.2) 2 (5.2)
Dystonic reactions 3 (7.9) 1 (2.6)
Seizures 1 (2.6)
Disorientation 1 (2.6)
Agitation 1 (2.6) 1 (2.6)
Tachycardia 6 (15.8)
Hypotension 5 (13.1) 1 (2.6)
QTc prolongation 8 (18.4) 1 (2.6)
AV block I 1 (2.6)
Xerostomia 3 (7.9)
Gastrointestinal symptoms 3 (7.9)
Urinary retention 1 (2.6)
